Su1721 ONE-YEAR COMPARISON OF CLINICAL AND ENDOSCOPIC OUTCOMES OF TOFACITINIB VERSUS VEDOLIZUMAB FOR ULCERATIVE COLITIS AFTER ANTI-TUMOR NECROSIS FACTOR FAILURE: A REAL-WORLD COHORT STUDY IN THE UNITED STATES
Gastroenterology（2023）
关键词
ulcerative colitis,endoscopic outcomes,vedolizumab,one-year,anti-tumor,real-world
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要